Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor–Positive Metastatic Breast Cancer: A Randomized Phase II StudyC. Kent Osborne, Mark Sellers, Luc Dirix et al.|Clinical Cancer Research|2011Cited by 181